# A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

> **NCT00232154** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 72 (actual)

## Conditions studied

- Sinusitis

## Interventions

- **DRUG:** Zithromax™ (azithromycin) 500mg tablets
- **PROCEDURE:** Endoscopic Sinus Surgery
- **PROCEDURE:** Blood sampling for hematology
- **PROCEDURE:** Blood sampling for plasma chemistry profile
- **PROCEDURE:** Serum pregnancy test (for women of child-bearing potential)

## Key facts

- **NCT ID:** NCT00232154
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232154, "A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00232154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*